{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e0a6ad5e",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd \n",
    "import numpy as np\n",
    "import os, sys\n",
    "from tqdm import tqdm\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "while os.getcwd().split('/')[-1] != 'rag-llm-cancer-paper':\n",
    "    os.chdir('..')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "1cec3a19",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(625, 6)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>statement_id</th>\n",
       "      <th>standardized_cancer</th>\n",
       "      <th>raw_cancer</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>therapy</th>\n",
       "      <th>modified_standardized_cancer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>B-Lymphoblastic Leukemia/Lymphoma</td>\n",
       "      <td>B-Lymphoblastic Leukemia/Lymphoma</td>\n",
       "      <td>[T315I]</td>\n",
       "      <td>[Ponatinib]</td>\n",
       "      <td>B-Lymphoblastic Leukemia/Lymphoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "      <td>[T315I]</td>\n",
       "      <td>[Ponatinib]</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "      <td>[T315I]</td>\n",
       "      <td>[Asciminib]</td>\n",
       "      <td>Chronic Myelogenous Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>[E17K]</td>\n",
       "      <td>[Capivasertib,Fulvestrant]</td>\n",
       "      <td>Breast Cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>[V600E]</td>\n",
       "      <td>[Dabrafenib]</td>\n",
       "      <td>Melanoma</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   statement_id                standardized_cancer  \\\n",
       "0             0  B-Lymphoblastic Leukemia/Lymphoma   \n",
       "1             1       Chronic Myelogenous Leukemia   \n",
       "2             2       Chronic Myelogenous Leukemia   \n",
       "3             3                      Breast Cancer   \n",
       "4             4                           Melanoma   \n",
       "\n",
       "                          raw_cancer biomarker                     therapy  \\\n",
       "0  B-Lymphoblastic Leukemia/Lymphoma   [T315I]                 [Ponatinib]   \n",
       "1       Chronic Myelogenous Leukemia   [T315I]                 [Ponatinib]   \n",
       "2       Chronic Myelogenous Leukemia   [T315I]                 [Asciminib]   \n",
       "3                      Breast Cancer    [E17K]  [Capivasertib,Fulvestrant]   \n",
       "4                           Melanoma   [V600E]                [Dabrafenib]   \n",
       "\n",
       "        modified_standardized_cancer  \n",
       "0  B-Lymphoblastic Leukemia/Lymphoma  \n",
       "1       Chronic Myelogenous Leukemia  \n",
       "2       Chronic Myelogenous Leukemia  \n",
       "3                      Breast Cancer  \n",
       "4                           Melanoma  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import ast\n",
    "standardized_to_raw_mapping = pd.read_csv('external-validation/non-moa-database/oncokb/oncokb-db/oncokb_core__2025-09.csv')\n",
    "standardized_to_raw_mapping = standardized_to_raw_mapping.rename(columns={'modified_standard_cancer':'modified_standardized_cancer'})\n",
    "standardized_to_raw_mapping['biomarker']=standardized_to_raw_mapping['biomarker'].apply(ast.literal_eval)\n",
    "standardized_to_raw_mapping['therapy']=standardized_to_raw_mapping['therapy'].apply(ast.literal_eval)\n",
    "print(standardized_to_raw_mapping.shape)\n",
    "standardized_to_raw_mapping.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "ac74c413",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_synthetic_query(db: dict) -> str:\n",
    "    \"\"\"\n",
    "    Create a synthetic query based on the database entry.\n",
    "    \"\"\"\n",
    "    if len(db['biomarker']) > 1:\n",
    "        biomarker_str = \", \".join(db['biomarker'])\n",
    "    else:\n",
    "        biomarker_str = db['biomarker'][0]\n",
    "    query_text=f\"if a patient with {db['modified_standardized_cancer']} cancer has {biomarker_str.lower()}, what therapy is recommended?\"\n",
    "    return query_text\n",
    "\n",
    "def create_synthetic_answer(db: dict) -> str:\n",
    "    \"\"\"\n",
    "    Create a synthetic answer based on the database entry.\n",
    "    \"\"\"\n",
    "    if len(db['biomarker']) > 1:\n",
    "        biomarker_str = \", \".join(db['biomarker'])\n",
    "    else:\n",
    "        biomarker_str = db['biomarker'][0]\n",
    "    if len(db['therapy']) > 1:\n",
    "        therapy_str = \" + \".join(db['therapy'])\n",
    "    else:\n",
    "        therapy_str = db['therapy'][0]\n",
    "    answer_text=f\"If a patient with {db['modified_standardized_cancer']} cancer has {biomarker_str.lower()}, one recommended therapy is {therapy_str.lower()}.\"\n",
    "    return answer_text\n",
    "\n",
    "synthetic_query_list = []\n",
    "synthetic_answer_list = []\n",
    "synthetic_query_therapy_pair_dict = {}\n",
    "for _, row in standardized_to_raw_mapping.iterrows():\n",
    "    #create synthetic query and answer and add to dataframe\n",
    "    query = create_synthetic_query(row)\n",
    "    answer = create_synthetic_answer(row)\n",
    "    standardized_to_raw_mapping.at[_, 'prompt'] = query\n",
    "    \n",
    "    #add more therapy context to answers (context db)\n",
    "    statements = pd.read_csv('external-validation/non-moa-database/civic/civic-db/civic-draft.dereferenced.unique.context_db.csv')\n",
    "    statement_dict = dict(zip(statements['statement_id'], statements['context']))\n",
    "\n",
    "    summary = statement_dict.get(row['statement_id'], \"No statement available.\")\n",
    "    #summary, stmt_row = flatten_statements(fda_statements[_])\n",
    "    # if len(stmt_row['therapy_type']) > 1:\n",
    "    #     therapy_type = ' + '.join(stmt_row['therapy_type'])\n",
    "    # else:\n",
    "    # #     therapy_type = stmt_row['therapy_type'][0]\n",
    "    # if len(stmt_row['therapy_strategy']) > 1:\n",
    "    #     therapy_strategy = ' + '.join(stmt_row['therapy_strategy'])\n",
    "    # else:\n",
    "    #     therapy_strategy = stmt_row['therapy_strategy'][0]\n",
    "        \n",
    "    standardized_to_raw_mapping.at[_, 'answer'] = (\n",
    "        #f\"{answer} therapy type: {therapy_type.lower()}. therapy strategy: {therapy_strategy.lower()}. indication: {stmt_row['indication'].lower()} approval url: {stmt_row['approval_url']}\"\n",
    "        f\"{answer}\"\n",
    "    )\n",
    "    \n",
    "    #create synthetic query and ground-truth mapping dict\n",
    "    row['therapy'] = [therapy.lower().strip() for therapy in row['therapy']]\n",
    "    if query in synthetic_query_therapy_pair_dict.keys():\n",
    "        synthetic_query_therapy_pair_dict[query].append(set(row['therapy']))\n",
    "    else:\n",
    "        synthetic_query_therapy_pair_dict[query] = [set(row['therapy'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "66bfbdaa",
   "metadata": {},
   "outputs": [],
   "source": [
    "#split ranges for testing on small batches\n",
    "import random, math\n",
    "def split_ranges(max_int, num_ranges, samples=None, seed=42):\n",
    "    random.seed(seed)\n",
    "    step = math.ceil(max_int / num_ranges)\n",
    "    ranges = [(i*step+1, min((i+1)*step, max_int)) for i in range(num_ranges)]\n",
    "    \n",
    "    if samples is None:\n",
    "        return ranges\n",
    "    \n",
    "    # split samples evenly across ranges\n",
    "    n_per_range = samples // num_ranges\n",
    "    remainder = samples % num_ranges\n",
    "    \n",
    "    result = []\n",
    "    for i, r in enumerate(ranges):\n",
    "        count = n_per_range + (1 if i < remainder else 0)\n",
    "        result.extend(random.randint(r[0], r[1]) for _ in range(count))\n",
    "    \n",
    "    return result\n",
    "test_idx_list = split_ranges(standardized_to_raw_mapping.shape[0], 10, 50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "790bd9b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 if a patient with Breast Cancer cancer has e380,s463p,y537,l536,l469v,d538, what therapy is recommended?\n",
      "1 if a patient with Biliary Tract cancer has v600e, what therapy is recommended?\n",
      "2 if a patient with Chronic Myelogenous Leukemia cancer has t315i, what therapy is recommended?\n",
      "3 if a patient with Oligodendroglioma cancer has r132s,r132l,r132c,r132h,r132g, what therapy is recommended?\n",
      "4 if a patient with Melanoma cancer has v600e,v600k, what therapy is recommended?\n",
      "5 if a patient with Pilocytic Astrocytoma cancer has v600e, what therapy is recommended?\n",
      "6 if a patient with Non-Small Cell Lung Cancer cancer has g1202r, what therapy is recommended?\n",
      "7 if a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, what therapy is recommended?\n",
      "8 if a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "9 if a patient with Breast Cancer cancer has c420r,e542k,e545a,e545d,e545g,e545k,q546e,q546r,h1047l,h1047r,h1047y, what therapy is recommended?\n",
      "10 if a patient with Histiocytosis cancer has v600, what therapy is recommended?\n"
     ]
    }
   ],
   "source": [
    "for i, e in enumerate(standardized_to_raw_mapping.loc[test_idx_list].prompt):\n",
    "    print(i, e)\n",
    "    if i == 10:\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "d59b0b0a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 If a patient with Breast Cancer cancer has e380,s463p,y537,l536,l469v,d538, one recommended therapy is elacestrant.\n",
      "1 If a patient with Biliary Tract cancer has v600e, one recommended therapy is dabrafenib,trametinib.\n",
      "2 If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is asciminib.\n",
      "3 If a patient with Oligodendroglioma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is vorasidenib.\n",
      "4 If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is trametinib.\n",
      "5 If a patient with Pilocytic Astrocytoma cancer has v600e, one recommended therapy is selumetinib.\n",
      "6 If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is lorlatinib.\n",
      "7 If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is nilotinib.\n",
      "8 If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is ado-trastuzumab emtansine.\n",
      "9 If a patient with Breast Cancer cancer has c420r,e542k,e545a,e545d,e545g,e545k,q546e,q546r,h1047l,h1047r,h1047y, one recommended therapy is capivasertib,fulvestrant.\n",
      "10 If a patient with Histiocytosis cancer has v600, one recommended therapy is dabrafenib.\n"
     ]
    }
   ],
   "source": [
    "for i, e in enumerate(standardized_to_raw_mapping.loc[test_idx_list].answer):\n",
    "    print(i, e)\n",
    "    if i == 10:\n",
    "        break"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a126d140",
   "metadata": {},
   "source": [
    "### generate synthetic queries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "ed9d44a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils.io import load_object, save_object\n",
    "save_object(synthetic_query_therapy_pair_dict, \n",
    "            \"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_query_therapy_pair_dict.pkl\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "111f91d2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "if a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, what therapy is recommended? [{'ponatinib'}, {'imatinib'}, {'dasatinib'}, {'nilotinib'}, {'bosutinib'}]\n"
     ]
    }
   ],
   "source": [
    "for k, v in synthetic_query_therapy_pair_dict.items():\n",
    "    print(k, v)\n",
    "    break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "5dd611e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "with open(f\"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_prompts__2025-09.json\", \"w\") as f:\n",
    "    json.dump(standardized_to_raw_mapping.prompt.to_list(), f)\n",
    "\n",
    "with open(f\"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_answers__2025-09.json\", \"w\") as f:\n",
    "    json.dump(standardized_to_raw_mapping.answer.to_list(), f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0e51d0ec",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is ponatinib.\n",
      "625\n"
     ]
    }
   ],
   "source": [
    "_CONTEXT = standardized_to_raw_mapping.answer.to_list()\n",
    "print(_CONTEXT[0])\n",
    "print(len(_CONTEXT))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ac618c58",
   "metadata": {},
   "outputs": [],
   "source": [
    "def _cache_paths(output_dir: str, embed_name: str, name: str, version: str = \"v1\"):\n",
    "    os.makedirs(output_dir, exist_ok=True)\n",
    "    return (\n",
    "        f\"{output_dir}/{embed_name}_{name}__{version}.faiss\",\n",
    "        f\"{output_dir}/{embed_name}_{name}__{version}.json\",\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "4bc446bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "from openai import OpenAI\n",
    "from utils.embedding import retrieve_context, get_text_embedding, store_embedding #get_context_db,\n",
    "def get_context_db(context_chunks, CLIENT, model_embed):\n",
    "    context_embeddings=np.array([get_text_embedding(chunk, CLIENT, model_embed) for chunk in context_chunks])\n",
    "    index=store_embedding(context_embeddings)\n",
    "    return(index)\n",
    "import faiss\n",
    "load_dotenv()\n",
    "api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "_CLIENT = OpenAI(api_key=api_key)\n",
    "_MODEL_EMBED = \"text-embedding-3-small\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "46762d58",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Always prefer cached index if present; only build once\n",
    "force_rebuild=True\n",
    "version = '2025-09'\n",
    "index_path, ctx_path =_cache_paths(\"external-validation/non-moa-database/oncokb/oncokb-db/indexes\", \n",
    "                                   _MODEL_EMBED, \n",
    "                                   \"structured_context\", version=version)\n",
    "context_json_path=f\"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_answers__{version}.json\"\n",
    "\n",
    "def build_index(context_json_path, index_path, ctx_path):\n",
    "    global _READY, _CLIENT, _CONTEXT, _INDEX, _MODEL_TYPE, _MODEL_NAME, _MODEL_EMBED\n",
    " \n",
    "    load_dotenv()\n",
    "    api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "    _CLIENT = OpenAI(api_key=api_key)\n",
    "    _MODEL_EMBED = \"text-embedding-3-small\"\n",
    "    \n",
    "    with open(context_json_path, \"r\") as f:\n",
    "            _CONTEXT = json.load(f)\n",
    "    _INDEX = get_context_db(_CONTEXT, _CLIENT, _MODEL_EMBED)\n",
    "    faiss.write_index(_INDEX, index_path)\n",
    "    with open(ctx_path, \"w\") as f:\n",
    "        json.dump(_CONTEXT, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "51bdacce",
   "metadata": {},
   "outputs": [],
   "source": [
    "index_path = 'external-validation/non-moa-database/oncokb/oncokb-db/index/oncokb_2025-09_structured_context.faiss'\n",
    "ctx_path = 'external-validation/non-moa-database/oncokb/oncokb-db/index/oncokb_2025-09_structured_context.json'\n",
    "context_json_path = f'external-validation/non-moa-database/oncokb/oncokb-db/synthetic_answers__{version}.json'\n",
    "build_index(context_json_path, index_path, ctx_path)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf932f78",
   "metadata": {},
   "source": [
    "### perform extraction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "7d2e0a6a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('context_retriever/biobert_ner/tokenizer_config.json',\n",
       " 'context_retriever/biobert_ner/special_tokens_map.json',\n",
       " 'context_retriever/biobert_ner/vocab.txt',\n",
       " 'context_retriever/biobert_ner/added_tokens.json',\n",
       " 'context_retriever/biobert_ner/tokenizer.json')"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "biobert_dir = \"context_retriever/biobert_ner\"\n",
    "#download model from huggingface\n",
    "from transformers import AutoTokenizer, AutoModelForTokenClassification\n",
    "model = AutoModelForTokenClassification.from_pretrained(\"judithrosell/BioBERT_BioNLP13CG_NER_new\")\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"judithrosell/BioBERT_BioNLP13CG_NER_new\")\n",
    "id2label = model.config.id2label\n",
    "\n",
    "#save locally\n",
    "model.save_pretrained(biobert_dir)\n",
    "tokenizer.save_pretrained(biobert_dir)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "79c8a4d1",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 625/625 [00:30<00:00, 20.75it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[{'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['anaplastic thyroid cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'low-grade glioma'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'low-grade glioma'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': ['v600k', 'v600e']},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l858r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l861q']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g815r', 'g776s', 'v777l', 'l755a', 'e717d']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['follicular lymphoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acute myeloid leukemia cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['intrahepatic cholangiocarcinoma cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['cholangiocarcinoma cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['myelodysplastic'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['oligodendroglioma cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['astrocytoma cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['acute myeloid leukemia cancer'],\n",
       "  'biomarker': ['r132l', 'r132s', 'r132c', 'r132g', 'r132h']},\n",
       " {'cancer_type': ['acute myeloid leukemia cancer'],\n",
       "  'biomarker': ['r172m',\n",
       "   'r140q',\n",
       "   'r140w',\n",
       "   'r172g',\n",
       "   'r172k',\n",
       "   'r140l',\n",
       "   'r172w',\n",
       "   'r140g',\n",
       "   'r172s']},\n",
       " {'cancer_type': ['oligodendroglioma cancer'],\n",
       "  'biomarker': ['r172m', 'r172g', 'r172k', 'r172w', 'r172s']},\n",
       " {'cancer_type': ['astrocytoma cancer'],\n",
       "  'biomarker': ['r172m', 'r172g', 'r172k', 'r172w', 'r172s']},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['mastocytosis cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['low-grade serous ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'],\n",
       "  'biomarker': ['e545a',\n",
       "   'h1047l',\n",
       "   'e542k',\n",
       "   'e545d',\n",
       "   'h1047y',\n",
       "   'h1047r',\n",
       "   'c420r',\n",
       "   'e545k',\n",
       "   'e545g']},\n",
       " {'cancer_type': ['breast cancer cancer'],\n",
       "  'biomarker': ['e545a',\n",
       "   'h1047l',\n",
       "   'e542k',\n",
       "   'e545d',\n",
       "   'h1047y',\n",
       "   'h1047r',\n",
       "   'c420r',\n",
       "   'e545k',\n",
       "   'e545g']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['f317c', 'f317v', 'v299l', 'f317i', 'f317l', 't315a']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['f317c', 'f317v', 'v299l', 'f317i', 'f317l', 't315a']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['pilocytic astrocytoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hairy cell leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['diffuse glioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['glioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pleomorphic xanthoastrocytoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pilocytic astrocytoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ganglioglioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l861q']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l861q']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l861q']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['cervical cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': ['v422del']},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['chondrosarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['oligodendroglioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['astrocytoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'],\n",
       "  'biomarker': ['v654a', 'v559a', 'k642e', 'v560d']},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['small bowel cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['ampullary cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['ampullary cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['small bowel cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'],\n",
       "  'biomarker': ['e545a',\n",
       "   'q546r',\n",
       "   'h1047l',\n",
       "   'e542k',\n",
       "   'e545d',\n",
       "   'h1047y',\n",
       "   'h1047r',\n",
       "   'c420r',\n",
       "   'e545k',\n",
       "   'e545g',\n",
       "   'q546e']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['small bowel cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['s478n', 'l474p']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['s478n', 'l474p']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['e318k', 's478n', 'd402n', 'l474p']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['e318k', 's478n', 'd402n', 'l474p']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['e318k', 's478n', 'd402n', 'l474p']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   's297f',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   's297f',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   's297f',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['colorectal cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   's297f',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['small bowel cancer cancer'],\n",
       "  'biomarker': ['p286r',\n",
       "   'v464a',\n",
       "   'v411l',\n",
       "   'p286l',\n",
       "   's461t',\n",
       "   'p286s',\n",
       "   's461p',\n",
       "   's459f',\n",
       "   'l424v',\n",
       "   'f367l',\n",
       "   'k425r',\n",
       "   'l424i',\n",
       "   'p436r',\n",
       "   'f367s',\n",
       "   'p286h',\n",
       "   's461l',\n",
       "   'p436s',\n",
       "   's297f',\n",
       "   'p436h',\n",
       "   'v411m']},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': ['e17k']},\n",
       " {'cancer_type': ['endometrial cancer cancer'], 'biomarker': ['e17k']},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': ['f1174l']},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': ['f1174c']},\n",
       " {'cancer_type': ['neuroblastoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': ['l597']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i', 'l858r', 'g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['s768i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': ['g719']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g724s']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l718v']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['glioma cancer'], 'biomarker': ['r132']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g12r', 'g12a', 'g12v', 'g12s', 'g12d']},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'],\n",
       "  'biomarker': ['g12r', 'g12a', 'g12v', 'g12s', 'g12d']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g12d', 'asp3082']},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'],\n",
       "  'biomarker': ['g12d', 'asp3082']},\n",
       " {'cancer_type': ['tubular adenoma', 'colon cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['esophagogastric cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['anal cancer cancer'], 'biomarker': ['g12c']},\n",
       " {'cancer_type': ['stomach cancer',\n",
       "   'esophagus',\n",
       "   'gastrointestinal neuroendocrine tumors'],\n",
       "  'biomarker': ['g12c']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['y1003']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['y1003']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['y1003']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['renal cell carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['renal cell carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g595r']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g623r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g2032r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l2086f']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'],\n",
       "  'biomarker': ['g469v', 'g464', 'g469r', 'g469a']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['l597']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l747p']},\n",
       " {'cancer_type': ['glioma cancer'], 'biomarker': ['r108k']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'],\n",
       "  'biomarker': ['g12r', 'g12a', 'g12v', 'g12s', 'g12d']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g12d']},\n",
       " {'cancer_type': ['all solid tumors cancer'],\n",
       "  'biomarker': ['g12d', 'asp3082']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['h1106d', 'v1092i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['v1092i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['v1092i']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g595r']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g623r']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['g250e', 'f317l', 'v299l']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['g250e', 'f317l', 'v299l']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['f317c', 'f317v', 'v299l', 'f317i', 'f317l', 't315a']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['f317c', 'f317v', 'v299l', 'f317i', 'f317l', 't315a']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['g250e',\n",
       "   'e255k',\n",
       "   'f359i',\n",
       "   'f317l',\n",
       "   'f317c',\n",
       "   'f317v',\n",
       "   'f359v',\n",
       "   'e255v',\n",
       "   'f359c',\n",
       "   'f317i',\n",
       "   'v299l',\n",
       "   't315a']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['g250e',\n",
       "   'y253h',\n",
       "   'f359i',\n",
       "   'f317l',\n",
       "   'f317c',\n",
       "   'f317v',\n",
       "   'f359v',\n",
       "   'f359c',\n",
       "   'f317i',\n",
       "   'v299l',\n",
       "   't315a']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': ['c481s']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g595r']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g623r']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g696a']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['f617l']},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1269a']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['i1171n']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g1202r']},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': ['t474s']},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': ['c481f']},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': ['c481r']},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['small lymphocytic lymphoma cancer',\n",
       "   'chronic lymphocytic leukemia'],\n",
       "  'biomarker': ['t474i']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['c797g']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g465r']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g465r']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g465e']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['g465e']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['c797s']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l792f']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['v441d']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['v441d']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['v441g']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['v441g']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g724s']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l718v']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['s464l']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': ['s464l']},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'],\n",
       "  'biomarker': ['v654a']},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['d1228n']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['d1228n']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['d1228n']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['g595r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g2032r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['g2032r']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l2086f']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['l2086f']},\n",
       " {'cancer_type': ['cancer', 'anaplastic large-cell lymphoma'],\n",
       "  'biomarker': ['alk']},\n",
       " {'cancer_type': ['inflammatory myofibroblastic tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'low-grade glioma'], 'biomarker': []},\n",
       " {'cancer_type': ['myeloid / lymphoid neoplasms'],\n",
       "  'biomarker': ['pdgfrb', 'pcm1', 'fgfr1', 'pdgfra', 'jak2']},\n",
       " {'cancer_type': ['cholangiocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['cholangiocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acute leukemias'], 'biomarker': []},\n",
       " {'cancer_type': ['acute myeloid leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['myelodysplastic', 'myeloproliferative neoplasms cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['myelodysplastic', 'myeloproliferative neoplasms cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['medullary thyroid cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['thyroid cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['thyroid cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['bcr-abl1']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['bcr-abl1']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['chronic myelogenous leukemia cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['bcr']},\n",
       " {'cancer_type': ['dermatofibrosarcoma protuberans cancer'],\n",
       "  'biomarker': ['col1a1', 'pdgfb']},\n",
       " {'cancer_type': ['apl'], 'biomarker': ['pml', 'pml-rara']},\n",
       " {'cancer_type': ['apl'], 'biomarker': ['pml', 'pml-rara']},\n",
       " {'cancer_type': ['apl'], 'biomarker': ['pml', 'pml-rara']},\n",
       " {'cancer_type': ['apl'], 'biomarker': ['pml', 'pml-rara']},\n",
       " {'cancer_type': ['inflammatory myofibroblastic tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['inflammatory myofibroblastic tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['inflammatory myofibroblastic tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['inflammatory myofibroblastic tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['pilocytic astrocytoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['erdheim-chester disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['langerhans cell histiocytosis cancer'],\n",
       "  'biomarker': ['v600']},\n",
       " {'cancer_type': ['rosai-dorfman disease cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['pancreatic cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['myeloid / lymphoid neoplasms'],\n",
       "  'biomarker': ['pdgfrb', 'pcm1', 'fgfr1', 'pdgfra', 'jak2']},\n",
       " {'cancer_type': ['myeloid / lymphoid neoplasms'],\n",
       "  'biomarker': ['pdgfrb', 'pcm1', 'fgfr1', 'pdgfra', 'jak2']},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['gastrointestinal stromal tumor cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['bcr-abl1']},\n",
       " {'cancer_type': ['b-lymphoblastic leukemia', 'lymphoma cancer'],\n",
       "  'biomarker': ['abl1', 'bcr']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['nvl-655']},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['melanoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['histiocytosis cancer'], 'biomarker': ['v600']},\n",
       " {'cancer_type': ['cholangiocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['medullary thyroid cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ewing sarcoma cancer'],\n",
       "  'biomarker': ['tk216', 'fli1', 'ewsr1']},\n",
       " {'cancer_type': ['soft tissue cancer', 'ewing sarcoma'],\n",
       "  'biomarker': ['tk216', 'fli1', 'ewsr1']},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['fallopian tube cancer', 'ovary /'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovary', 'fallopian tube cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovary', 'fallopian tube cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['fallopian tube cancer', 'ovary /'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['fallopian tube cancer', 'ovary /'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovary', 'fallopian tube cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovary', 'fallopian tube cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['peritoneal serous carcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['neurofibroma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['neurofibroma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['nos cancer', 'prostate cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['prostate cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['epithelioid sarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['encapsulated glioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acinar cell carcinoma', 'pancreas cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['uterine sarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acinar cell carcinoma', 'pancreas cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['uterine sarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['uterine sarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['salivary gland cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['uterine serous carcinoma',\n",
       "   'uterine papillary serous carcinoma cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['salivary gland cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['salivary gland cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['colorectal cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['salivary gland cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['salivary gland cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['follicular lymphoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acinar cell carcinoma', 'pancreas cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acinar cell carcinoma', 'pancreas cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['pancreatic adenocarcinoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['acinar cell carcinoma', 'pancreas cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['breast cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['endometrial cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophagogastric cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['endometrial cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['intimal sarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['well-differentiated liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['hepatobiliary cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['biliary tract cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['mrtx1719']},\n",
       " {'cancer_type': ['acute myeloid leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['ovarian cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['endometrial cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['esophageal adenocarcinoma cancer'],\n",
       "  'biomarker': ['prt3789']},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'],\n",
       "  'biomarker': ['prt3789']},\n",
       " {'cancer_type': ['perivascular epithelioid cell tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['uterine perivascular epithelioid cell tumor cancer'],\n",
       "  'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['well-differentiated liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['well-differentiated liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['glioma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['bladder cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['well-differentiated liposarcoma cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': ['gsk2636771']},\n",
       " {'cancer_type': ['all solid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['all liquid tumors cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['chronic myelomonocytic leukemia cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['myelodysplastic syndromes cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []},\n",
       " {'cancer_type': ['non-small cell lung cancer cancer'], 'biomarker': []}]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "version = '2025-09'\n",
    "import json\n",
    "context_json_path = f'external-validation/non-moa-database/oncokb/oncokb-db/synthetic_answers__{version}.json'\n",
    "with open(context_json_path, \"r\") as f:\n",
    "    _CONTEXT = json.load(f)\n",
    "#run BioBert NER on all contexts\n",
    "from utils.entity_prediction import extract_entities, db_extract_entities\n",
    "context_extracted_entities = []\n",
    "for ctx in tqdm(_CONTEXT):\n",
    "    context_extracted_entities.append(extract_entities(ctx, model, tokenizer))\n",
    "context_extracted_entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "9c72d0e7",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "625it [00:00, 1315983.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.000%\n",
      "67.520%\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "no_cancer_idx = []\n",
    "no_biomarker_idx = []\n",
    "for i, e in tqdm(enumerate(context_extracted_entities)):\n",
    "    if not e['cancer_type']:\n",
    "        no_cancer_idx.append(i)\n",
    "    if not e['biomarker']:\n",
    "        no_biomarker_idx.append(i)\n",
    "\n",
    "print(f\"{len(no_cancer_idx)*100/len(_CONTEXT):.3f}%\") #no cancer entity extracted %\n",
    "print(f\"{len(no_biomarker_idx)*100/len(_CONTEXT):.3f}%\") #no biomarker entity extracted %"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "f924f043",
   "metadata": {},
   "outputs": [],
   "source": [
    "#save\n",
    "os.makedirs(\"external-validation/non-moa-database/oncokb/oncokb-db/context_retriever/entities\", exist_ok=True)\n",
    "with open(f\"external-validation/non-moa-database/oncokb/oncokb-db/context_retriever/entities/synthetic_query_ner_entities__{version}.json\", \"w\") as f:\n",
    "    json.dump(context_extracted_entities, f, indent=4)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "41897169",
   "metadata": {},
   "source": [
    "### create validation test dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f841116c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>statement_id</th>\n",
       "      <th>standardized_cancer</th>\n",
       "      <th>raw_cancer</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>therapy</th>\n",
       "      <th>modified_standardized_cancer</th>\n",
       "      <th>prompt</th>\n",
       "      <th>answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>447</th>\n",
       "      <td>447</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>[Oncogenic Mutations]</td>\n",
       "      <td>[Rucaparib]</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>if a patient with Prostate Cancer cancer has o...</td>\n",
       "      <td>If a patient with Prostate Cancer cancer has o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>485</th>\n",
       "      <td>485</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>[Oncogenic Mutations]</td>\n",
       "      <td>[Olaparib]</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>if a patient with Prostate Cancer, NOS cancer ...</td>\n",
       "      <td>If a patient with Prostate Cancer, NOS cancer ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>215</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>[G469A,G469R,G469V,G464]</td>\n",
       "      <td>[Plixorafenib]</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>if a patient with All Solid Tumors cancer has ...</td>\n",
       "      <td>If a patient with All Solid Tumors cancer has ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>212</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>[G2032R]</td>\n",
       "      <td>[Taletrectinib]</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>if a patient with Non-Small Cell Lung Cancer c...</td>\n",
       "      <td>If a patient with Non-Small Cell Lung Cancer c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>480</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>[Oncogenic Mutations]</td>\n",
       "      <td>[Olaparib]</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>if a patient with Prostate Cancer cancer has o...</td>\n",
       "      <td>If a patient with Prostate Cancer cancer has o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>434</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>[Oncogenic Mutations]</td>\n",
       "      <td>[Talazoparib,Enzalutamide]</td>\n",
       "      <td>Prostate Cancer, NOS</td>\n",
       "      <td>if a patient with Prostate Cancer, NOS cancer ...</td>\n",
       "      <td>If a patient with Prostate Cancer, NOS cancer ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>210</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>[G595R]</td>\n",
       "      <td>[Selitrectinib]</td>\n",
       "      <td>All Solid Tumors</td>\n",
       "      <td>if a patient with All Solid Tumors cancer has ...</td>\n",
       "      <td>If a patient with All Solid Tumors cancer has ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>30</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>[Exon 19 in-frame deletions,L858R]</td>\n",
       "      <td>[Osimertinib]</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>if a patient with Non-Small Cell Lung Cancer c...</td>\n",
       "      <td>If a patient with Non-Small Cell Lung Cancer c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>579</th>\n",
       "      <td>579</td>\n",
       "      <td>Hepatobiliary Cancer</td>\n",
       "      <td>Hepatobiliary Cancer</td>\n",
       "      <td>[Amplification]</td>\n",
       "      <td>[Brigimadlin]</td>\n",
       "      <td>Hepatobiliary Cancer</td>\n",
       "      <td>if a patient with Hepatobiliary Cancer cancer ...</td>\n",
       "      <td>If a patient with Hepatobiliary Cancer cancer ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>482</th>\n",
       "      <td>482</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>[Oncogenic Mutations]</td>\n",
       "      <td>[Olaparib]</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>if a patient with Prostate Cancer cancer has o...</td>\n",
       "      <td>If a patient with Prostate Cancer cancer has o...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>62 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     statement_id         standardized_cancer                  raw_cancer  \\\n",
       "447           447             Prostate Cancer             Prostate Cancer   \n",
       "485           485        Prostate Cancer, NOS        Prostate Cancer, NOS   \n",
       "215           215            All Solid Tumors            All Solid Tumors   \n",
       "212           212  Non-Small Cell Lung Cancer  Non-Small Cell Lung Cancer   \n",
       "480           480             Prostate Cancer             Prostate Cancer   \n",
       "..            ...                         ...                         ...   \n",
       "434           434        Prostate Cancer, NOS        Prostate Cancer, NOS   \n",
       "210           210            All Solid Tumors            All Solid Tumors   \n",
       "30             30  Non-Small Cell Lung Cancer  Non-Small Cell Lung Cancer   \n",
       "579           579        Hepatobiliary Cancer        Hepatobiliary Cancer   \n",
       "482           482             Prostate Cancer             Prostate Cancer   \n",
       "\n",
       "                              biomarker                     therapy  \\\n",
       "447               [Oncogenic Mutations]                 [Rucaparib]   \n",
       "485               [Oncogenic Mutations]                  [Olaparib]   \n",
       "215            [G469A,G469R,G469V,G464]              [Plixorafenib]   \n",
       "212                            [G2032R]             [Taletrectinib]   \n",
       "480               [Oncogenic Mutations]                  [Olaparib]   \n",
       "..                                  ...                         ...   \n",
       "434               [Oncogenic Mutations]  [Talazoparib,Enzalutamide]   \n",
       "210                             [G595R]             [Selitrectinib]   \n",
       "30   [Exon 19 in-frame deletions,L858R]               [Osimertinib]   \n",
       "579                     [Amplification]               [Brigimadlin]   \n",
       "482               [Oncogenic Mutations]                  [Olaparib]   \n",
       "\n",
       "    modified_standardized_cancer  \\\n",
       "447              Prostate Cancer   \n",
       "485         Prostate Cancer, NOS   \n",
       "215             All Solid Tumors   \n",
       "212   Non-Small Cell Lung Cancer   \n",
       "480              Prostate Cancer   \n",
       "..                           ...   \n",
       "434         Prostate Cancer, NOS   \n",
       "210             All Solid Tumors   \n",
       "30    Non-Small Cell Lung Cancer   \n",
       "579         Hepatobiliary Cancer   \n",
       "482              Prostate Cancer   \n",
       "\n",
       "                                                prompt  \\\n",
       "447  if a patient with Prostate Cancer cancer has o...   \n",
       "485  if a patient with Prostate Cancer, NOS cancer ...   \n",
       "215  if a patient with All Solid Tumors cancer has ...   \n",
       "212  if a patient with Non-Small Cell Lung Cancer c...   \n",
       "480  if a patient with Prostate Cancer cancer has o...   \n",
       "..                                                 ...   \n",
       "434  if a patient with Prostate Cancer, NOS cancer ...   \n",
       "210  if a patient with All Solid Tumors cancer has ...   \n",
       "30   if a patient with Non-Small Cell Lung Cancer c...   \n",
       "579  if a patient with Hepatobiliary Cancer cancer ...   \n",
       "482  if a patient with Prostate Cancer cancer has o...   \n",
       "\n",
       "                                                answer  \n",
       "447  If a patient with Prostate Cancer cancer has o...  \n",
       "485  If a patient with Prostate Cancer, NOS cancer ...  \n",
       "215  If a patient with All Solid Tumors cancer has ...  \n",
       "212  If a patient with Non-Small Cell Lung Cancer c...  \n",
       "480  If a patient with Prostate Cancer cancer has o...  \n",
       "..                                                 ...  \n",
       "434  If a patient with Prostate Cancer, NOS cancer ...  \n",
       "210  If a patient with All Solid Tumors cancer has ...  \n",
       "30   If a patient with Non-Small Cell Lung Cancer c...  \n",
       "579  If a patient with Hepatobiliary Cancer cancer ...  \n",
       "482  If a patient with Prostate Cancer cancer has o...  \n",
       "\n",
       "[62 rows x 8 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standardized_to_raw_mapping_subset=standardized_to_raw_mapping.sample(frac=.1, random_state=42)\n",
    "standardized_to_raw_mapping_subset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "9b1095dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "standardized_to_raw_mapping_subset.to_csv(\"external-validation/non-moa-database/oncokb/oncokb-db/oncokb_small_testing_dataset.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "2febe239",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>statement_id</th>\n",
       "      <th>standardized_cancer</th>\n",
       "      <th>raw_cancer</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>therapy</th>\n",
       "      <th>modified_standardized_cancer</th>\n",
       "      <th>prompt</th>\n",
       "      <th>answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>447</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>['Oncogenic Mutations']</td>\n",
       "      <td>['Rucaparib']</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>if a patient with Prostate Cancer cancer has o...</td>\n",
       "      <td>If a patient with Prostate Cancer cancer has o...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   statement_id standardized_cancer       raw_cancer                biomarker  \\\n",
       "0           447     Prostate Cancer  Prostate Cancer  ['Oncogenic Mutations']   \n",
       "\n",
       "         therapy modified_standardized_cancer  \\\n",
       "0  ['Rucaparib']              Prostate Cancer   \n",
       "\n",
       "                                              prompt  \\\n",
       "0  if a patient with Prostate Cancer cancer has o...   \n",
       "\n",
       "                                              answer  \n",
       "0  If a patient with Prostate Cancer cancer has o...  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standardized_to_raw_mapping_subset = pd.read_csv(\"external-validation/non-moa-database/oncokb/oncokb-db/oncokb_small_testing_dataset.csv\")\n",
    "standardized_to_raw_mapping_subset.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "b7d0300f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# chunks: 62\n",
      "Min: 17\n",
      "Max: 114\n",
      "Mean: 25.79032258064516\n",
      "Median: 21.0\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "np.int64(1599)"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import tiktoken\n",
    "encoding = tiktoken.encoding_for_model(\"gpt-4o\")\n",
    "query_size=[len(encoding.encode(prompt)) for prompt in standardized_to_raw_mapping_subset.prompt]\n",
    "print(\"# chunks: \"+str(len(query_size)))\n",
    "print(\"Min: \"+str(np.min(query_size)))\n",
    "print(\"Max: \"+str(np.max(query_size)))\n",
    "print(\"Mean: \"+str(np.mean(query_size)))\n",
    "print(\"Median: \"+str(np.median(query_size)))\n",
    "np.sum(query_size)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "e99f320b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# chunks: 62\n",
      "Min: 21\n",
      "Max: 119\n",
      "Mean: 30.306451612903224\n",
      "Median: 27.0\n"
     ]
    }
   ],
   "source": [
    "query_size=[len(encoding.encode(prompt)) for prompt in standardized_to_raw_mapping_subset.answer]\n",
    "print(\"# chunks: \"+str(len(query_size)))\n",
    "print(\"Min: \"+str(np.min(query_size)))\n",
    "print(\"Max: \"+str(np.max(query_size)))\n",
    "print(\"Mean: \"+str(np.mean(query_size)))\n",
    "print(\"Median: \"+str(np.median(query_size)))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "91ea1fa9",
   "metadata": {},
   "source": [
    "### perform evaluation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "d58d0b52",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>statement_id</th>\n",
       "      <th>standardized_cancer</th>\n",
       "      <th>raw_cancer</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>therapy</th>\n",
       "      <th>modified_standardized_cancer</th>\n",
       "      <th>prompt</th>\n",
       "      <th>answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>447</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>['Oncogenic Mutations']</td>\n",
       "      <td>['Rucaparib']</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>if a patient with Prostate Cancer cancer has o...</td>\n",
       "      <td>If a patient with Prostate Cancer cancer has o...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   statement_id standardized_cancer       raw_cancer                biomarker  \\\n",
       "0           447     Prostate Cancer  Prostate Cancer  ['Oncogenic Mutations']   \n",
       "\n",
       "         therapy modified_standardized_cancer  \\\n",
       "0  ['Rucaparib']              Prostate Cancer   \n",
       "\n",
       "                                              prompt  \\\n",
       "0  if a patient with Prostate Cancer cancer has o...   \n",
       "\n",
       "                                              answer  \n",
       "0  If a patient with Prostate Cancer cancer has o...  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standardized_to_raw_mapping_subset = pd.read_csv(\"external-validation/non-moa-database/oncokb/oncokb-db/oncokb_small_testing_dataset.csv\")\n",
    "standardized_to_raw_mapping_subset.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "86757eea",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ================== GENERAL IMPORTS ==================\n",
    "import os\n",
    "import json\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "# ================== UTIL FUNCTIONS ==================\n",
    "from utils.embedding import retrieve_context, get_text_embedding, store_embedding #get_context_db,\n",
    "from utils.prompt import get_prompt\n",
    "from llm.run_RAGLLM import run_RAG\n",
    "\n",
    "# Generate context vector database\n",
    "def get_context_db(context_chunks, CLIENT, model_embed):\n",
    "    context_embeddings=np.array([get_text_embedding(chunk, CLIENT, model_embed) for chunk in context_chunks])\n",
    "    index=store_embedding(context_embeddings)\n",
    "    return(index)\n",
    "from utils.io import load_object, save_object\n",
    "\n",
    "\n",
    "# ================== MODEL & API IMPORTS ==================\n",
    "from mistralai.client import MistralClient\n",
    "from openai import OpenAI\n",
    "from llm.inference import run_llm\n",
    "import faiss\n",
    "synthetic_query_therapy_pair_dict=load_object(\"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_query_therapy_pair_dict.pkl\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "462ed81c",
   "metadata": {},
   "outputs": [],
   "source": [
    "#setup env\n",
    "import faiss\n",
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "_MODEL = 'gpt-4.1-nano' #this could be gpt-4o-2024-05-13, gpt-4o-mini-2024-07-18, etc.\n",
    "_MODEL_EMBED = 'text-embedding-3-small'\n",
    "api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "if not api_key:\n",
    "    raise ValueError(\"Missing API key. Please set OPENAI_API_KEY in your .env file.\")\n",
    "CLIENT=OpenAI(api_key=api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "518a11a3",
   "metadata": {},
   "outputs": [],
   "source": [
    "_VERSION = '2025-09-04'\n",
    "version = '2025-09'\n",
    "_QUERY_DF=pd.read_csv(\"external-validation/non-moa-database/oncokb/oncokb-db/oncokb_small_testing_dataset.csv\",)\n",
    "context_json_path=f\"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_answers__{version}.json\"\n",
    "with open(context_json_path, \"r\") as f:\n",
    "     _CONTEXT = json.load(f)\n",
    "index_path = 'external-validation/non-moa-database/oncokb/oncokb-db/index/oncokb_2025-09_structured_context.faiss'\n",
    "_INDEX = faiss.read_index(index_path)\n",
    "with open(f\"context_retriever/entities/oncokb_db_context_ner_entities__oncokb-202509.json\", \"r\") as f:\n",
    "     _DB_ENTITY = json.load(f)\n",
    "with open(f\"external-validation/non-moa-database/oncokb/oncokb-db/context_retriever/entities/synthetic_query_ner_entities__{version}.json\", \"r\") as f:\n",
    "    _QUERY_ENTITY = json.load(f)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "89279301",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time elapsed for iteration 0: 2.7345 min\n"
     ]
    }
   ],
   "source": [
    "# Run RAG-LLM iterations\n",
    "from llm.run_RAGLLM import run_iterations_rag\n",
    "output_ls, input_ls, runtime_ls = run_iterations_rag(\n",
    "    num_iterations=1,#args.num_iter, \n",
    "    data=_QUERY_DF, \n",
    "    context_chunks=_CONTEXT, \n",
    "    db_entity=_DB_ENTITY,\n",
    "    query_entity=_QUERY_ENTITY, \n",
    "    num_vec=10, \n",
    "    index=_INDEX,\n",
    "    client=CLIENT, \n",
    "    model=_MODEL, \n",
    "    model_embed=_MODEL_EMBED, \n",
    "    model_type='gpt',\n",
    "    strategy=5,\n",
    "    max_len=None, \n",
    "    temp=0.0, \n",
    "    random_seed=None\n",
    "    )\n",
    "\n",
    "# Save results\n",
    "res_dict = {\n",
    "    \"full output\": output_ls, \n",
    "    \"input prompt\": input_ls, \n",
    "    #\"retrieval\": retrieval_ls,\n",
    "    \"runtime\": runtime_ls\n",
    "    }\n",
    "\n",
    "os.makedirs('external-validation/non-moa-database/oncokb/rag-llm/small-test', exist_ok=True)\n",
    "output_dir = 'external-validation/non-moa-database/oncokb/rag-llm/small-test'\n",
    "\n",
    "result_file=os.path.join(\n",
    "    output_dir,\n",
    "    f'RAGstra{str(5)}n{str(1)}temp{str(0)}_res_dict.pkl'\n",
    ")\n",
    "from utils.io import save_object\n",
    "save_object(res_dict, filename=result_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "50cf8516",
   "metadata": {},
   "outputs": [],
   "source": [
    "output_res = os.path.join(\n",
    "    output_dir,\n",
    "    f'RAGstra{str(5)}n{str(1)}temp{str(0)}_res_dict.pkl'\n",
    ")\n",
    "output_res = load_object(output_res)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "9ef647d1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'avg_exact_match_acc': 0.3387096774193548,\n",
       " 'avg_partial_match_acc': 0.8387096774193549,\n",
       " 'avg_precision': 0.8360215053763441,\n",
       " 'avg_recall': 0.4759056579621095,\n",
       " 'avg_f1': 0.540991235203759,\n",
       " 'avg_specificity': 0.9990092973561309,\n",
       " 'exact_match_acc': [False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False,\n",
       "  False],\n",
       " 'partial_match_acc': [True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True,\n",
       "  True,\n",
       "  False,\n",
       "  True],\n",
       " 'precision_ls': [1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.8333333333333334,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  1.0],\n",
       " 'recall_ls': [0.2,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  0.3333333333333333,\n",
       "  0.2,\n",
       "  0.2,\n",
       "  1.0,\n",
       "  0.5,\n",
       "  0.0,\n",
       "  0.25,\n",
       "  0.25,\n",
       "  0.1111111111111111,\n",
       "  0.25,\n",
       "  0.5,\n",
       "  0.5,\n",
       "  1.0,\n",
       "  0.16666666666666666,\n",
       "  0.2,\n",
       "  0.3333333333333333,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.25,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.14285714285714285,\n",
       "  0.5,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.14285714285714285,\n",
       "  0.14285714285714285,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.0625,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.2,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.8333333333333334,\n",
       "  0.5,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.2,\n",
       "  0.16666666666666666,\n",
       "  1.0,\n",
       "  0.14285714285714285,\n",
       "  0.16666666666666666,\n",
       "  0.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.5,\n",
       "  1.0,\n",
       "  0.0,\n",
       "  0.25,\n",
       "  0.1111111111111111,\n",
       "  0.0,\n",
       "  0.2],\n",
       " 'f1_ls': [0.33333333333333337,\n",
       "  0,\n",
       "  1.0,\n",
       "  0.5,\n",
       "  0.33333333333333337,\n",
       "  0.33333333333333337,\n",
       "  1.0,\n",
       "  0.6666666666666666,\n",
       "  0,\n",
       "  0.4,\n",
       "  0.4,\n",
       "  0.19999999999999998,\n",
       "  0.4,\n",
       "  0.6666666666666666,\n",
       "  0.6666666666666666,\n",
       "  1.0,\n",
       "  0.2857142857142857,\n",
       "  0.33333333333333337,\n",
       "  0.5,\n",
       "  1.0,\n",
       "  0,\n",
       "  0.4,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0,\n",
       "  0.25,\n",
       "  0.6666666666666666,\n",
       "  0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.25,\n",
       "  0.25,\n",
       "  1.0,\n",
       "  0,\n",
       "  0.11764705882352941,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.33333333333333337,\n",
       "  1.0,\n",
       "  0,\n",
       "  0.8333333333333334,\n",
       "  0.6666666666666666,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.33333333333333337,\n",
       "  0.2857142857142857,\n",
       "  1.0,\n",
       "  0.25,\n",
       "  0.2857142857142857,\n",
       "  0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.6666666666666666,\n",
       "  1.0,\n",
       "  0,\n",
       "  0.4,\n",
       "  0.19999999999999998,\n",
       "  0,\n",
       "  0.33333333333333337],\n",
       " 'specificity_ls': [1.0,\n",
       "  0.9943820224719101,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9943820224719101,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9944444444444445,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9943820224719101,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.994475138121547,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9943820224719101,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9944444444444445,\n",
       "  0.9944444444444445,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.994413407821229,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9943820224719101,\n",
       "  1.0,\n",
       "  1.0,\n",
       "  0.9944444444444445,\n",
       "  1.0],\n",
       " 'pred_drugs_generic_set_ls': [{frozenset({'olaparib'})},\n",
       "  {frozenset({'talazoparib'})},\n",
       "  {frozenset({'plixorafenib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'olaparib'})},\n",
       "  {frozenset({'olaparib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'talazoparib'})},\n",
       "  {frozenset({'nivolumab'})},\n",
       "  {frozenset({'osimertinib'})},\n",
       "  {frozenset({'erlotinib'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'cobimetinib'})},\n",
       "  {frozenset({'rucaparib'})},\n",
       "  {frozenset({'dasatinib'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'pemigatinib'})},\n",
       "  {frozenset({'ibrutinib'})},\n",
       "  {frozenset({'adagrasib'})},\n",
       "  {frozenset({'nivolumab'})},\n",
       "  {frozenset({'vorasidenib'})},\n",
       "  {frozenset({'ceralasertib'})},\n",
       "  {frozenset({'talazoparib'})},\n",
       "  {frozenset({'dacomitinib'})},\n",
       "  {frozenset({'nilotinib'})},\n",
       "  {frozenset({'camonsertib', 'lunresertib'})},\n",
       "  {frozenset({'ceralasertib'})},\n",
       "  {frozenset({'bosutinib'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'brigatinib'})},\n",
       "  {frozenset({'nilotinib'})},\n",
       "  {frozenset({'afatinib'})},\n",
       "  {frozenset({'gefitinib'})},\n",
       "  {frozenset({'sotorasib'}), frozenset({'adagrasib'})},\n",
       "  {frozenset({'talazoparib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'afatinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'brigatinib'})},\n",
       "  {frozenset({'zongertinib'})},\n",
       "  {frozenset({'cobimetinib', 'vemurafenib'})},\n",
       "  {frozenset({'lunresertib'}),\n",
       "   frozenset({'blu-222'}),\n",
       "   frozenset({'trastuzumab deruxtecan'}),\n",
       "   frozenset({'lirafugratinib'}),\n",
       "   frozenset({'camonsertib', 'lunresertib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'everolimus'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'olaparib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'pemigatinib'}), frozenset({'futibatinib'})},\n",
       "  {frozenset({'gefitinib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'cobimetinib', 'vemurafenib'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'sotorasib'}), frozenset({'adagrasib'})},\n",
       "  {frozenset({'talazoparib'})},\n",
       "  {frozenset({'entrectinib'})},\n",
       "  {frozenset({'erlotinib'})},\n",
       "  {frozenset({'trastuzumab', 'tucatinib'})},\n",
       "  {frozenset({'olaparib'})}],\n",
       " 'true_drugs_generic_set_ls': [{frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'plixorafenib'})},\n",
       "  {frozenset({'lorlatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'taletrectinib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'lorlatinib'})},\n",
       "  {frozenset({'crizotinib'}), frozenset({'lorlatinib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'pembrolizumab'}),\n",
       "   frozenset({'ipilimumab,nivolumab'}),\n",
       "   frozenset({'nivolumab'}),\n",
       "   frozenset({'dostarlimab'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'afatinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'osimertinib'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'amivantamab,lazertinib'}),\n",
       "   frozenset({'afatinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'erlotinib,ramucirumab'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'osimertinib,chemotherapy'}),\n",
       "   frozenset({'dacomitinib'}),\n",
       "   frozenset({'amivantamab,chemotherapy'})},\n",
       "  {frozenset({'regorafenib'}),\n",
       "   frozenset({'imatinib'}),\n",
       "   frozenset({'ripretinib'}),\n",
       "   frozenset({'sunitinib'})},\n",
       "  {frozenset({'cobimetinib'}), frozenset({'trametinib'})},\n",
       "  {frozenset({'rucaparib'}), frozenset({'olaparib'})},\n",
       "  {frozenset({'dasatinib'})},\n",
       "  {frozenset({'nilotinib'}),\n",
       "   frozenset({'bosutinib'}),\n",
       "   frozenset({'ponatinib'}),\n",
       "   frozenset({'dasatinib'}),\n",
       "   frozenset({'imatinib'}),\n",
       "   frozenset({'asciminib'})},\n",
       "  {frozenset({'nilotinib'}),\n",
       "   frozenset({'bosutinib'}),\n",
       "   frozenset({'dasatinib'}),\n",
       "   frozenset({'imatinib'}),\n",
       "   frozenset({'asciminib'})},\n",
       "  {frozenset({'fedratinib'}),\n",
       "   frozenset({'ruxolitinib'}),\n",
       "   frozenset({'pemigatinib'})},\n",
       "  {frozenset({'ibrutinib'})},\n",
       "  {frozenset({'adagrasib,panitumumab'}),\n",
       "   frozenset({'sotorasib,cetuximab'}),\n",
       "   frozenset({'sotorasib,panitumumab'}),\n",
       "   frozenset({'adagrasib,cetuximab'})},\n",
       "  {frozenset({'pembrolizumab'}),\n",
       "   frozenset({'ipilimumab,nivolumab'}),\n",
       "   frozenset({'nivolumab'}),\n",
       "   frozenset({'dostarlimab'})},\n",
       "  {frozenset({'vorasidenib'})},\n",
       "  {frozenset({'ceralasertib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'amivantamab,lazertinib'}),\n",
       "   frozenset({'afatinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'dacomitinib'}),\n",
       "   frozenset({'amivantamab,chemotherapy'})},\n",
       "  {frozenset({'nilotinib'}), frozenset({'dasatinib'})},\n",
       "  {frozenset({'lunresertib,camonsertib'})},\n",
       "  {frozenset({'ceralasertib'})},\n",
       "  {frozenset({'bosutinib'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'brigatinib'})},\n",
       "  {frozenset({'nilotinib'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'amivantamab,lazertinib'}),\n",
       "   frozenset({'afatinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'dacomitinib'}),\n",
       "   frozenset({'amivantamab,chemotherapy'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'tepotinib'}),\n",
       "   frozenset({'capmatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'telisotuzumab vedotin'})},\n",
       "  {frozenset({'sotorasib'}), frozenset({'adagrasib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'repotrectinib'}),\n",
       "   frozenset({'zenocutuzumab'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'entrectinib'}),\n",
       "   frozenset({'ensartinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'taletrectinib'}),\n",
       "   frozenset({'selpercatinib'}),\n",
       "   frozenset({'nvl-655'}),\n",
       "   frozenset({'vandetanib'}),\n",
       "   frozenset({'pralsetinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'seribantumab'}),\n",
       "   frozenset({'brigatinib'}),\n",
       "   frozenset({'cabozantinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'afatinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'brigatinib'})},\n",
       "  {frozenset({'zongertinib'})},\n",
       "  {frozenset({'vemurafenib,cobimetinib'})},\n",
       "  {frozenset({'lunresertib'}),\n",
       "   frozenset({'blu-222'}),\n",
       "   frozenset({'lunresertib,camonsertib'}),\n",
       "   frozenset({'trastuzumab deruxtecan'}),\n",
       "   frozenset({'lirafugratinib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'imatinib'}), frozenset({'sunitinib'})},\n",
       "  {frozenset({'everolimus'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'nvl-655'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'brigatinib'})},\n",
       "  {frozenset({'futibatinib'}), frozenset({'pemigatinib'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'tepotinib'}),\n",
       "   frozenset({'capmatinib'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'telisotuzumab vedotin'})},\n",
       "  {frozenset({'ceritinib'}),\n",
       "   frozenset({'alectinib'}),\n",
       "   frozenset({'lorlatinib'}),\n",
       "   frozenset({'nvl-655'}),\n",
       "   frozenset({'crizotinib'}),\n",
       "   frozenset({'brigatinib'})},\n",
       "  {frozenset({'dabrafenib,trametinib'}),\n",
       "   frozenset({'vemurafenib,cobimetinib'}),\n",
       "   frozenset({'trametinib'}),\n",
       "   frozenset({'encorafenib,binimetinib'})},\n",
       "  {frozenset({'imatinib'})},\n",
       "  {frozenset({'palbociclib'}),\n",
       "   frozenset({'milademetan'}),\n",
       "   frozenset({'abemaciclib'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'imatinib'}), frozenset({'sunitinib'})},\n",
       "  {frozenset({'sotorasib'}), frozenset({'adagrasib'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})},\n",
       "  {frozenset({'larotrectinib'}),\n",
       "   frozenset({'zurletrectinib'}),\n",
       "   frozenset({'entrectinib'}),\n",
       "   frozenset({'selitrectinib'})},\n",
       "  {frozenset({'erlotinib'}),\n",
       "   frozenset({'amivantamab,lazertinib'}),\n",
       "   frozenset({'afatinib'}),\n",
       "   frozenset({'gefitinib'}),\n",
       "   frozenset({'erlotinib,ramucirumab'}),\n",
       "   frozenset({'osimertinib'}),\n",
       "   frozenset({'osimertinib,chemotherapy'}),\n",
       "   frozenset({'dacomitinib'}),\n",
       "   frozenset({'amivantamab,chemotherapy'})},\n",
       "  {frozenset({'trastuzumab,pertuzumab'}),\n",
       "   frozenset({'zanidatamab'}),\n",
       "   frozenset({'brigimadlin,ezabenlimab'}),\n",
       "   frozenset({'tucatinib,trastuzumab'}),\n",
       "   frozenset({'brigimadlin'})},\n",
       "  {frozenset({'olaparib,abiraterone,prednisone'}),\n",
       "   frozenset({'rucaparib'}),\n",
       "   frozenset({'niraparib,abiraterone acetate,prednisone'}),\n",
       "   frozenset({'talazoparib,enzalutamide'}),\n",
       "   frozenset({'olaparib'})}]}"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from utils.evaluation import calc_eval_metrics\n",
    "\n",
    "output_eval = calc_eval_metrics(output_res['full output'][0], \n",
    "                                standardized_to_raw_mapping_subset.reset_index(drop=True)['prompt'], \n",
    "                                synthetic_query_therapy_pair_dict)\n",
    "output_eval"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "ec7174ea",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index([ 0,  1,  3,  4,  5,  7,  8,  9, 10, 11, 12, 13, 14, 16, 17, 18, 20, 21,\n",
      "       24, 25, 26, 27, 32, 33, 35, 36, 40, 42, 43, 44, 47, 48, 50, 51, 52, 55,\n",
      "       57, 58, 59, 60, 61],\n",
      "      dtype='int64')\n"
     ]
    }
   ],
   "source": [
    "exact_failed_ind = standardized_to_raw_mapping_subset.reset_index(drop=True)[~np.array(output_eval['exact_match_acc'])].index\n",
    "print(exact_failed_ind)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "db44b4dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "from utils.io import load_object, save_object\n",
    "synthetic_query_therapy_pair_dict = load_object(\n",
    "            \"external-validation/non-moa-database/oncokb/oncokb-db/synthetic_query_therapy_pair_dict.pkl\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "bb72c751",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"oncogenic mutations\",\n",
      "    \"Drug Name\": \"olaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved for prostate cancer with homologous recombination repair gene mutations\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lynporilza-olaparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer, NOS\",\n",
      "    \"Disease Phase or Condition\": \"has oncogenic mutations\",\n",
      "    \"Drug Name\": \"talazoparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/talazoparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has g2032r, what therapy is recommended?\n",
      "[{'taletrectinib'}, {'crizotinib'}, {'lorlatinib'}]\n",
      "3\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g2032r, one recommended therapy is taletrectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1269a, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l718v, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has g2032r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with g2032r mutation\",\n",
      "    \"Drug Name\": \"lorlatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"g2032r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lorlatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Oncogenic mutations\",\n",
      "    \"Drug Name\": \"olaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/olaparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Oncogenic mutations\",\n",
      "    \"Drug Name\": \"olaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/olaparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has l1196m, what therapy is recommended?\n",
      "[{'lorlatinib'}, {'crizotinib'}]\n",
      "2\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has i1171n, one recommended therapy is alectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is alectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1269a, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l718v, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has d761y, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has l1196m, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with L1196M mutation\",\n",
      "    \"Drug Name\": \"Lorlatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"L1196M mutation\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lorlatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer, NOS\",\n",
      "    \"Disease Phase or Condition\": \"has oncogenic mutations\",\n",
      "    \"Drug Name\": \"talazoparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/talazoparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, what therapy is recommended?\n",
      "[{'dostarlimab'}, {'ipilimumab,nivolumab'}, {'nivolumab'}, {'pembrolizumab'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.', 'If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is pembrolizumab.', 'If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is ipilimumab,nivolumab.', 'If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is dostarlimab.', 'If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is dostarlimab.', 'If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is pembrolizumab.', 'If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is nivolumab.', 'If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.', 'If a patient with Small Bowel Cancer cancer has d368n,d275v,d275g,d275a,a463v,a463t,a463d,a288v,s461l,k425r,v464a,v411l,p286r,p286s,p286h,s459f,l424v,l424i,f367s,s297f,s297y,a456p,p436r,m295r,v411m,m444k,d368y,f367v,s459y,p286l,y458h,y458c,s461t,s461p,p436s,p436h,f367l, one recommended therapy is ipilimumab,nivolumab.', 'If a patient with Small Bowel Cancer cancer has g12c, one recommended therapy is sotorasib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Small Bowel Cancer\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"nivolumab\",\n",
      "    \"Prior Treatment or Resistance Status\": null,\n",
      "    \"Genomic Features\": [\"d402n\", \"l474p\", \"s478n\", \"e318k\"],\n",
      "    \"FDA-approval status\": \"FDA-approved\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has t790m, what therapy is recommended?\n",
      "[{'osimertinib'}, {'erlotinib'}, {'gefitinib'}, {'afatinib'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has t790m, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.', 'If a patient with Melanoma cancer has l597, one recommended therapy is trametinib.', 'If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is trametinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has t790m, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"t790m mutation\",\n",
      "    \"Drug Name\": \"osimertinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"resistance or mutation positive\",\n",
      "    \"Genomic Features\": \"t790m\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/osimertinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, what therapy is recommended?\n",
      "[{'erlotinib'}, {'osimertinib,chemotherapy'}, {'amivantamab,chemotherapy'}, {'erlotinib,ramucirumab'}, {'afatinib'}, {'amivantamab,lazertinib'}, {'gefitinib'}, {'osimertinib'}, {'dacomitinib'}]\n",
      "9\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib,ramucirumab.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q,exon 19 in-frame deletions,exon 19 in-frame insertions,l858r,s768i,g719, one recommended therapy is patritumab deruxtecan.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with exon 19 in-frame deletions, l858r\",\n",
      "    \"Drug Name\": \"erlotinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"exon 19 in-frame deletions, l858r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s056lbl.pdf\"\n",
      "  }\n",
      "}\n",
      "if a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'imatinib'}, {'sunitinib'}, {'regorafenib'}, {'ripretinib'}, {'imatinib'}, {'sunitinib'}, {'regorafenib'}, {'ripretinib'}, {'imatinib'}, {'sunitinib'}, {'regorafenib'}, {'ripretinib'}]\n",
      "12\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is regorafenib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, one recommended therapy is ripretinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Gastrointestinal Stromal Tumor cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Gastrointestinal Stromal Tumor (GIST) cancer\",\n",
      "    \"Disease Phase or Condition\": \"Oncogenic mutations present\",\n",
      "    \"Drug Name\": \"Imatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020507s017lbl.pdf\"\n",
      "  }\n",
      "}\n",
      "if a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), what therapy is recommended?\n",
      "[{'cobimetinib'}, {'trametinib'}, {'cobimetinib'}, {'trametinib'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.', 'If a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.', 'If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.', 'If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is trametinib.', 'If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Histiocytosis cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Rosai-Dorfman Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Langerhans Cell Histiocytosis cancer has oncogenic mutations (excluding v600), what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Langerhans Cell Histiocytosis\",\n",
      "    \"Disease Phase or Condition\": \"cancer with oncogenic mutations (excluding v600)\",\n",
      "    \"Drug Name\": \"cobimetinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations (excluding v600)\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204956s006lbl.pdf\"\n",
      "  }\n",
      "}\n",
      "if a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'rucaparib'}, {'rucaparib'}, {'rucaparib'}, {'olaparib'}, {'olaparib'}]\n",
      "5\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.', 'If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.', 'If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, one recommended therapy is rucaparib.', 'If a patient with Pancreatic Adenocarcinoma cancer has fusions, one recommended therapy is zenocutuzumab.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is sotorasib.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12d, one recommended therapy is asp3082.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12a,g12d,g12r,g12s,g12v, one recommended therapy is daraxonrasib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Pancreatic Adenocarcinoma cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Pancreatic Adenocarcinoma\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with oncogenic mutations\",\n",
      "    \"Drug Name\": \"rucaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/rucaparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Chronic Myelogenous Leukemia cancer has t315i, what therapy is recommended?\n",
      "[{'ponatinib'}, {'asciminib'}, {'imatinib'}, {'dasatinib'}, {'nilotinib'}, {'bosutinib'}]\n",
      "6\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is imatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is nilotinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is asciminib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is dasatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is bosutinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is ponatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is nilotinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is dasatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has y253h,f359v,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v, one recommended therapy is bosutinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has v299l,f317l,g250e, one recommended therapy is bosutinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Chronic Myelogenous Leukemia cancer has t315i, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Chronic Myelogenous Leukemia\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"imatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"t315i\",\n",
      "    \"Genomic Features\": [\"t315i\"],\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/imatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, what therapy is recommended?\n",
      "[{'imatinib'}, {'nilotinib'}, {'dasatinib'}, {'bosutinib'}, {'asciminib'}]\n",
      "5\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is nilotinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is imatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is dasatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is asciminib.', 'If a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, one recommended therapy is bosutinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is imatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is asciminib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is bosutinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is dasatinib.', 'If a patient with Chronic Myelogenous Leukemia cancer has t315i, one recommended therapy is nilotinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Chronic Myelogenous Leukemia cancer has bcr-abl1 fusion, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Chronic Myelogenous Leukemia\",\n",
      "    \"Disease Phase or Condition\": \"cancer with bcr-abl1 fusion\",\n",
      "    \"Drug Name\": \"imatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"bcr-abl1 fusion\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020839s056lbl.pdf\"\n",
      "  }\n",
      "}\n",
      "if a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, what therapy is recommended?\n",
      "[{'pemigatinib'}, {'ruxolitinib'}, {'fedratinib'}]\n",
      "3\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is pemigatinib.', 'If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is ruxolitinib.', 'If a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, one recommended therapy is fedratinib.', 'If a patient with Melanoma cancer has v600e, one recommended therapy is dabrafenib.', 'If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is encorafenib,binimetinib.', 'If a patient with Hairy Cell Leukemia cancer has v600e, one recommended therapy is vemurafenib.', 'If a patient with Erdheim-Chester Disease cancer has oncogenic mutations, one recommended therapy is cobimetinib.', 'If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Erdheim-Chester Disease cancer has oncogenic mutations (excluding v600), one recommended therapy is cobimetinib.', 'If a patient with Pleomorphic Xanthoastrocytoma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 cancer has fusions, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA/PDGFRB or FGFR1 or PCM1-JAK2\",\n",
      "    \"Disease Phase or Condition\": \"with fusions\",\n",
      "    \"Drug Name\": \"pemigatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Rearrangements of PDGFRA/PDGFRB or FGFR1 or PCM1-JAK2 with fusions\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/pemigatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Colorectal Cancer cancer has g12c, what therapy is recommended?\n",
      "[{'adagrasib,cetuximab'}, {'sotorasib,panitumumab'}, {'adagrasib,panitumumab'}, {'sotorasib,cetuximab'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is adagrasib,cetuximab.', 'If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is sotorasib,cetuximab.', 'If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is adagrasib,panitumumab.', 'If a patient with Colorectal Cancer cancer has g12c, one recommended therapy is sotorasib,panitumumab.', 'If a patient with Anal Cancer cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Esophagogastric Cancer cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Ampullary Cancer cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Ampullary Cancer cancer has g12c, one recommended therapy is sotorasib.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Pancreatic Adenocarcinoma cancer has g12c, one recommended therapy is sotorasib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Colorectal Cancer cancer has g12c, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Colorectal Cancer\",\n",
      "    \"Disease Phase or Condition\": \"g12c mutation\",\n",
      "    \"Drug Name\": \"adagrasib\",\n",
      "    \"Prior Treatment or Resistance Status\": null,\n",
      "    \"Genomic Features\": \"g12c\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs\"\n",
      "  }\n",
      "}\n",
      "if a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, what therapy is recommended?\n",
      "[{'dostarlimab'}, {'ipilimumab,nivolumab'}, {'nivolumab'}, {'pembrolizumab'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.', 'If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is pembrolizumab.', 'If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is ipilimumab,nivolumab.', 'If a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is dostarlimab.', 'If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is nivolumab.', 'If a patient with Small Bowel Cancer cancer has d402n,l474p,s478n,e318k, one recommended therapy is dostarlimab.', 'If a patient with Colorectal Cancer cancer has s492r, one recommended therapy is cetuximab.', 'If a patient with Colorectal Cancer cancer has v441d, one recommended therapy is cetuximab.', 'If a patient with Colorectal Cancer cancer has v441g, one recommended therapy is cetuximab.', 'If a patient with Colorectal Cancer cancer has g465e, one recommended therapy is panitumumab.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Colorectal Cancer cancer has d402n,l474p,s478n,e318k, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Colorectal Cancer\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"nivolumab\",\n",
      "    \"Prior Treatment or Resistance Status\": \"\",\n",
      "    \"Genomic Features\": [\"d402n\", \"l474p\", \"s478n\", \"e318k\"],\n",
      "    \"FDA-approval status\": \"FDA-approved\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Oncogenic mutations\",\n",
      "    \"Drug Name\": \"talazoparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/talazoparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has l861q, what therapy is recommended?\n",
      "[{'afatinib'}, {'dacomitinib'}, {'erlotinib'}, {'osimertinib'}, {'gefitinib'}, {'amivantamab,chemotherapy'}, {'amivantamab,lazertinib'}]\n",
      "7\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is dacomitinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has l861q, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with L861Q mutation\",\n",
      "    \"Drug Name\": \"dacomitinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"L861Q mutation\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/dacomitinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, what therapy is recommended?\n",
      "[{'nilotinib'}, {'dasatinib'}]\n",
      "2\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is nilotinib.', 'If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, one recommended therapy is dasatinib.', 'If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,g250e, one recommended therapy is bosutinib.', 'If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has y253h,f359v,f359c,f317i,f317c,f359i,t315a,f317v,e255k,e255v, one recommended therapy is bosutinib.', 'If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has y253h,f359v,f359c,f359i,e255k,e255v, one recommended therapy is dasatinib.', 'If a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has t315i, one recommended therapy is ponatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is gefitinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with B-Lymphoblastic Leukemia/Lymphoma cancer has v299l,f317l,f317i,f317c,t315a,f317v, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"B-Lymphoblastic Leukemia/Lymphoma\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"nilotinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": [\"v299l\", \"f317l\", \"f317i\", \"f317c\", \"t315a\", \"f317v\"],\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/nilotinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Endometrial Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'lunresertib,camonsertib'}, {'lunresertib,camonsertib'}]\n",
      "2\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Endometrial Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.', 'If a patient with Endometrial Cancer cancer has oncogenic mutations, one recommended therapy is lunresertib,camonsertib.', 'If a patient with Endometrial Cancer cancer has e17k, one recommended therapy is capivasertib.', 'If a patient with Endometrial Cancer cancer has amplification, one recommended therapy is lunresertib,camonsertib.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is trastuzumab deruxtecan.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is trastuzumab,pertuzumab,docetaxel.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is neratinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is bemcentinib,pembrolizumab.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is sevabertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has oncogenic mutations, one recommended therapy is zongertinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Endometrial Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Endometrial Cancer\",\n",
      "    \"Disease Phase or Condition\": \"oncogenic mutations\",\n",
      "    \"Drug Name\": \"lunresertib, camonsertib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"Not specified in the provided data\",\n",
      "    \"Link to FDA-approved Label\": \"N/A\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has l861q, what therapy is recommended?\n",
      "[{'afatinib'}, {'dacomitinib'}, {'erlotinib'}, {'osimertinib'}, {'gefitinib'}, {'amivantamab,chemotherapy'}, {'amivantamab,lazertinib'}]\n",
      "7\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is amivantamab,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has s768i, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is crizotinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has l861q, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Genomic mutation: L861Q\",\n",
      "    \"Drug Name\": \"afatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"L861Q\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/afatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has amplification, what therapy is recommended?\n",
      "[{'crizotinib'}, {'capmatinib'}, {'tepotinib'}, {'telisotuzumab vedotin'}, {'erlotinib'}, {'gefitinib'}, {'osimertinib'}]\n",
      "7\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is tepotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is capmatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is telisotuzumab vedotin.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has i1171n, one recommended therapy is alectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is lorlatinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has amplification, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"amplification\",\n",
      "    \"Drug Name\": \"gefitinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/gefitinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer, NOS\",\n",
      "    \"Disease Phase or Condition\": \"has oncogenic mutations\",\n",
      "    \"Drug Name\": \"talazoparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/talazoparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has fusions, what therapy is recommended?\n",
      "[{'crizotinib'}, {'ceritinib'}, {'ensartinib'}, {'alectinib'}, {'brigatinib'}, {'lorlatinib'}, {'zenocutuzumab'}, {'selpercatinib'}, {'pralsetinib'}, {'crizotinib'}, {'taletrectinib'}, {'entrectinib'}, {'repotrectinib'}, {'cabozantinib'}, {'ceritinib'}, {'lorlatinib'}, {'nvl-655'}, {'seribantumab'}, {'vandetanib'}]\n",
      "19\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is zenocutuzumab.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is seribantumab.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is vandetanib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is nvl-655.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is ceritinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is entrectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is taletrectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is brigatinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has fusions, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Fusions\",\n",
      "    \"Drug Name\": \"lorlatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Fusions\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lorlatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, what therapy is recommended?\n",
      "[{'crizotinib'}, {'ceritinib'}, {'brigatinib'}, {'lorlatinib'}, {'alectinib'}]\n",
      "5\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is brigatinib.', 'If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is ceritinib.', 'If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is lorlatinib.', 'If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is alectinib.', 'If a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with All Solid Tumors cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is repotrectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is brigatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is taletrectinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Inflammatory Myofibroblastic Tumor cancer has fusions, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Inflammatory Myofibroblastic Tumor cancer\",\n",
      "    \"Disease Phase or Condition\": \"has fusions\",\n",
      "    \"Drug Name\": \"brigatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"fusions\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/brigatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Ganglioglioma cancer has v600e, what therapy is recommended?\n",
      "[{'vemurafenib,cobimetinib'}]\n",
      "1\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Ganglioglioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Encapsulated Glioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Diffuse Glioma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Pilocytic Astrocytoma cancer has v600e, one recommended therapy is selumetinib.', 'If a patient with Pleomorphic Xanthoastrocytoma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Pilocytic Astrocytoma cancer has v600e, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Melanoma cancer has v600e, one recommended therapy is vemurafenib.', 'If a patient with Melanoma cancer has v600e, one recommended therapy is dabrafenib.', 'If a patient with Non-Small Cell Lung Cancer cancer has v600e, one recommended therapy is encorafenib,binimetinib.', 'If a patient with Biliary Tract cancer has v600e, one recommended therapy is dabrafenib,trametinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Ganglioglioma cancer has v600e, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Ganglioglioma\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"vemurafenib, cobimetinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"v600e\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/vemurafenib\"\n",
      "  }\n",
      "}\n",
      "if a patient with All Solid Tumors cancer has amplification, what therapy is recommended?\n",
      "[{'trastuzumab deruxtecan'}, {'lunresertib'}, {'lunresertib,camonsertib'}, {'blu-222'}, {'lirafugratinib'}, {'brigimadlin'}]\n",
      "6\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lunresertib.', 'If a patient with All Solid Tumors cancer has amplification, one recommended therapy is brigimadlin.', 'If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lirafugratinib.', 'If a patient with All Solid Tumors cancer has amplification, one recommended therapy is blu-222.', 'If a patient with All Solid Tumors cancer has amplification, one recommended therapy is trastuzumab deruxtecan.', 'If a patient with All Solid Tumors cancer has amplification, one recommended therapy is lunresertib,camonsertib.', 'If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is azd8186.', 'If a patient with All Solid Tumors cancer has fusions, one recommended therapy is zenocutuzumab.', 'If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is gsk2636771.', 'If a patient with All Solid Tumors cancer has fusions, one recommended therapy is repotrectinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with All Solid Tumors cancer has amplification, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"lunresertib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  },\n",
      "  \"Treatment 2\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"brigimadlin\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  },\n",
      "  \"Treatment 3\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"lirafugratinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  },\n",
      "  \"Treatment 4\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"blu-222\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  },\n",
      "  \"Treatment 5\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"trastuzumab deruxtecan\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  },\n",
      "  \"Treatment 6\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Amplification\",\n",
      "    \"Drug Name\": \"lunresertib, camonsertib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov\"\n",
      "  }\n",
      "}\n",
      "if a patient with Gastrointestinal Stromal Tumor cancer has d816, what therapy is recommended?\n",
      "[{'imatinib'}, {'sunitinib'}]\n",
      "2\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Gastrointestinal Stromal Tumor cancer has d816, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d816, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d842v, one recommended therapy is dasatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is sorafenib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is nilotinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has n822, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has y823d, one recommended therapy is imatinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Gastrointestinal Stromal Tumor cancer has d816, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Gastrointestinal Stromal Tumor\",\n",
      "    \"Disease Phase or Condition\": \"cancer\",\n",
      "    \"Drug Name\": \"imatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"none specified\",\n",
      "    \"Genomic Features\": \"d816\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/imatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Oncogenic mutations\",\n",
      "    \"Drug Name\": \"olaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"Oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/olaparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has g1202r, what therapy is recommended?\n",
      "[{'lorlatinib'}, {'nvl-655'}, {'alectinib'}, {'crizotinib'}, {'ceritinib'}, {'brigatinib'}]\n",
      "6\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is alectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is ceritinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is nvl-655.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is brigatinib.', 'If a patient with Astrocytoma cancer has r132s,r132l,r132c,r132h,r132g, one recommended therapy is vorasidenib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1269a, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l1196m, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g719, one recommended therapy is afatinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has g1202r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer with g1202r mutation\",\n",
      "    \"Drug Name\": \"lorlatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"Resistance mutation g1202r\",\n",
      "    \"Genomic Features\": \"g1202r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lorlatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has amplification, what therapy is recommended?\n",
      "[{'crizotinib'}, {'capmatinib'}, {'tepotinib'}, {'telisotuzumab vedotin'}, {'erlotinib'}, {'gefitinib'}, {'osimertinib'}]\n",
      "7\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is tepotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is capmatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is telisotuzumab vedotin.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has l718v, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has fusions, one recommended therapy is vandetanib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has amplification, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"amplification\",\n",
      "    \"Drug Name\": \"gefitinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/gefitinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has g1202r, what therapy is recommended?\n",
      "[{'lorlatinib'}, {'nvl-655'}, {'alectinib'}, {'crizotinib'}, {'ceritinib'}, {'brigatinib'}]\n",
      "6\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is lorlatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is alectinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is crizotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is ceritinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is nvl-655.', 'If a patient with Non-Small Cell Lung Cancer cancer has g1202r, one recommended therapy is brigatinib.', 'If a patient with Acute Myeloid Leukemia cancer has r172k,r172m,r172s,r140l,r140g,r140w,r172w,r140q,r172g, one recommended therapy is enasidenib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has amplification, one recommended therapy is osimertinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has g1202r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"cancer with g1202r mutation\",\n",
      "    \"Drug Name\": \"lorlatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"resistance mutation g1202r\",\n",
      "    \"Genomic Features\": \"g1202r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lorlatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Melanoma cancer has v600e,v600k, what therapy is recommended?\n",
      "[{'dabrafenib,trametinib'}, {'trametinib'}, {'vemurafenib,cobimetinib'}, {'encorafenib,binimetinib'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is vemurafenib,cobimetinib.', 'If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is encorafenib,binimetinib.', 'If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is trametinib.', 'If a patient with Melanoma cancer has v600e,v600k, one recommended therapy is dabrafenib,trametinib.', 'If a patient with Melanoma cancer has v600e, one recommended therapy is vemurafenib.', 'If a patient with Melanoma cancer has v600e, one recommended therapy is dabrafenib.', 'If a patient with Melanoma cancer has v600, one recommended therapy is vemurafenib,atezolizumab,cobimetinib.', 'If a patient with Oligodendroglioma cancer has r172k,r172m,r172s,r172w,r172g, one recommended therapy is vorasidenib.', 'If a patient with Melanoma cancer has v654a,k642e,v560d,v560g,v560del,y553_k558del,p577del,l576p,w557g,l576del,w557r,d579del,v559a, one recommended therapy is imatinib.', 'If a patient with Astrocytoma cancer has r172k,r172m,r172s,r172w,r172g, one recommended therapy is vorasidenib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Melanoma cancer has v600e,v600k, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Melanoma\",\n",
      "    \"Disease Phase or Condition\": \"cancer with v600e,v600k mutations\",\n",
      "    \"Drug Name\": \"vemurafenib, cobimetinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": [\"v600e\", \"v600k\"],\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/vemurafenib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Gastrointestinal Stromal Tumor cancer has y823d, what therapy is recommended?\n",
      "[{'imatinib'}, {'sunitinib'}]\n",
      "2\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Gastrointestinal Stromal Tumor cancer has y823d, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has y823d, one recommended therapy is sunitinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is nilotinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is sorafenib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d842v, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has c809g,a829p,d816,d820,n822,y823d, one recommended therapy is pazopanib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has n822, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has a829p, one recommended therapy is imatinib.', 'If a patient with Gastrointestinal Stromal Tumor cancer has d820, one recommended therapy is sunitinib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Gastrointestinal Stromal Tumor cancer has y823d, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Gastrointestinal Stromal Tumor cancer\",\n",
      "    \"Disease Phase or Condition\": \"y823d mutation\",\n",
      "    \"Drug Name\": \"imatinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"y823d\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020788s037lbl.pdf\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer, NOS cancer has oncogenic mutations, one recommended therapy is olaparib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer, NOS cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer, NOS\",\n",
      "    \"Disease Phase or Condition\": \"has oncogenic mutations\",\n",
      "    \"Drug Name\": \"talazoparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/talazoparib\"\n",
      "  }\n",
      "}\n",
      "if a patient with All Solid Tumors cancer has g595r, what therapy is recommended?\n",
      "[{'selitrectinib'}, {'zurletrectinib'}, {'larotrectinib'}, {'entrectinib'}]\n",
      "4\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with All Solid Tumors cancer has g595r, one recommended therapy is entrectinib.', 'If a patient with All Solid Tumors cancer has g595r, one recommended therapy is larotrectinib.', 'If a patient with All Solid Tumors cancer has g595r, one recommended therapy is selitrectinib.', 'If a patient with All Solid Tumors cancer has g595r, one recommended therapy is zurletrectinib.', 'If a patient with All Solid Tumors cancer has g696a, one recommended therapy is larotrectinib.', 'If a patient with All Solid Tumors cancer has g623r, one recommended therapy is larotrectinib.', 'If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is rly-2608.', 'If a patient with All Solid Tumors cancer has f617l, one recommended therapy is larotrectinib.', 'If a patient with All Solid Tumors cancer has oncogenic mutations, one recommended therapy is gsk2636771.', 'If a patient with All Solid Tumors cancer has g469a,g469r,g469v,g464, one recommended therapy is plixorafenib.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with All Solid Tumors cancer has g595r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"All Solid Tumors\",\n",
      "    \"Disease Phase or Condition\": \"Cancer\",\n",
      "    \"Drug Name\": \"entrectinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"g595r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/entrectinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, what therapy is recommended?\n",
      "[{'erlotinib'}, {'osimertinib,chemotherapy'}, {'amivantamab,chemotherapy'}, {'erlotinib,ramucirumab'}, {'afatinib'}, {'amivantamab,lazertinib'}, {'gefitinib'}, {'osimertinib'}, {'dacomitinib'}]\n",
      "9\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is afatinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is erlotinib,ramucirumab.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is gefitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,lazertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is dacomitinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is osimertinib.', 'If a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, one recommended therapy is amivantamab,chemotherapy.', 'If a patient with Non-Small Cell Lung Cancer cancer has l861q,exon 19 in-frame deletions,exon 19 in-frame insertions,l858r,s768i,g719, one recommended therapy is patritumab deruxtecan.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Non-Small Cell Lung Cancer cancer has exon 19 in-frame deletions,l858r, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Non-Small Cell Lung Cancer\",\n",
      "    \"Disease Phase or Condition\": \"Cancer\",\n",
      "    \"Drug Name\": \"erlotinib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"exon 19 in-frame deletions, l858r\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/erlotinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Hepatobiliary Cancer cancer has amplification, what therapy is recommended?\n",
      "[{'trastuzumab,pertuzumab'}, {'tucatinib,trastuzumab'}, {'zanidatamab'}, {'brigimadlin'}, {'brigimadlin,ezabenlimab'}]\n",
      "5\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is tucatinib,trastuzumab.', 'If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.', 'If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is zanidatamab.', 'If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is brigimadlin,ezabenlimab.', 'If a patient with Hepatobiliary Cancer cancer has amplification, one recommended therapy is brigimadlin.', 'If a patient with Hepatobiliary Cancer cancer has g12c, one recommended therapy is adagrasib.', 'If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is lapatinib,trastuzumab.', 'If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is tucatinib,trastuzumab.', 'If a patient with Ampullary Cancer cancer has g12c, one recommended therapy is sotorasib.', 'If a patient with Colorectal Cancer cancer has amplification, one recommended therapy is trastuzumab,pertuzumab.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Hepatobiliary Cancer cancer has amplification, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Hepatobiliary Cancer\",\n",
      "    \"Disease Phase or Condition\": \"cancer with amplification\",\n",
      "    \"Drug Name\": \"tucatinib, trastuzumab\",\n",
      "    \"Prior Treatment or Resistance Status\": \"N/A\",\n",
      "    \"Genomic Features\": \"amplification\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/tucatinib\"\n",
      "  }\n",
      "}\n",
      "if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "[{'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'rucaparib'}, {'olaparib,abiraterone,prednisone'}, {'talazoparib,enzalutamide'}, {'niraparib,abiraterone acetate,prednisone'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}, {'olaparib'}, {'talazoparib,enzalutamide'}, {'olaparib'}]\n",
      "31\n",
      "\n",
      "    Context information is below.\n",
      "    ---------------------\n",
      "    ['If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is talazoparib,enzalutamide.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.', 'If a patient with Prostate Cancer cancer has oncogenic mutations, one recommended therapy is olaparib,abiraterone,prednisone.']\n",
      "    ---------------------\n",
      "    \n",
      "    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"no_match\",\n",
      "        \"Message\": \"No drugs are FDA-approved for the provided context\"\n",
      "    }\n",
      "    \n",
      "    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n",
      "    {\n",
      "        \"Status\": \"success\",\n",
      "        \"Treatment 1\": {\n",
      "            \"Disease Name\": ,\n",
      "            \"Disease Phase or Condition\": ,\n",
      "            \"Drug Name\": ,\n",
      "            \"Prior Treatment or Resistance Status\": ,\n",
      "            \"Genomic Features\": \n",
      "            \"FDA-approval status\":\n",
      "            \"Link to FDA-approved Label\":\n",
      "            }\n",
      "    }\n",
      "    Query: if a patient with Prostate Cancer cancer has oncogenic mutations, what therapy is recommended?\n",
      "     \n",
      "    \n",
      "{\n",
      "  \"Status\": \"success\",\n",
      "  \"Treatment 1\": {\n",
      "    \"Disease Name\": \"Prostate Cancer\",\n",
      "    \"Disease Phase or Condition\": \"with oncogenic mutations\",\n",
      "    \"Drug Name\": \"olaparib\",\n",
      "    \"Prior Treatment or Resistance Status\": \"not specified\",\n",
      "    \"Genomic Features\": \"oncogenic mutations\",\n",
      "    \"FDA-approval status\": \"FDA-approved\",\n",
      "    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/lynparza-olaparib\"\n",
      "  }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "num_true_drugs_list = []\n",
    "cancer_types = []\n",
    "biomarkers = []\n",
    "for i, row in standardized_to_raw_mapping_subset.reset_index(drop=True)[~np.array(output_eval['exact_match_acc'])].iterrows():\n",
    "    print(row['prompt'])\n",
    "    print(synthetic_query_therapy_pair_dict[row['prompt']])\n",
    "    num_true_drugs_list.append(len(synthetic_query_therapy_pair_dict[row['prompt']]))\n",
    "    print(len(synthetic_query_therapy_pair_dict[row['prompt']]))\n",
    "    print(output_res['input prompt'][0][i])\n",
    "    print(output_res['full output'][0][i])\n",
    "    cancer_types.append(row['standardized_cancer'])\n",
    "    biomarkers.append(row['biomarker'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "a5c9138c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[31, 31, 3, 31, 31, 2, 31, 4, 4, 9, 12, 4, 5, 6, 5, 3, 4, 4, 31, 7, 2, 2, 7, 7, 31, 19, 5, 1, 6, 2, 31, 6, 7, 6, 4, 2, 31, 4, 9, 5, 31]\n",
      "1\n",
      "11.609756097560975\n",
      "6.0\n",
      "31\n"
     ]
    }
   ],
   "source": [
    "print(num_true_drugs_list)\n",
    "print(np.min(num_true_drugs_list))\n",
    "print(np.mean(num_true_drugs_list))\n",
    "print(np.median(num_true_drugs_list))\n",
    "print(np.max(num_true_drugs_list))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "33032cfe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Non-Small Cell Lung Cancer', 12),\n",
       " ('Prostate Cancer', 6),\n",
       " ('Prostate Cancer, NOS', 4),\n",
       " ('Gastrointestinal Stromal Tumor', 3),\n",
       " ('Chronic Myelogenous Leukemia', 2),\n",
       " ('Colorectal Cancer', 2),\n",
       " ('All Solid Tumors', 2),\n",
       " ('Small Bowel Cancer', 1),\n",
       " ('Langerhans Cell Histiocytosis', 1),\n",
       " ('Pancreatic Adenocarcinoma', 1),\n",
       " ('Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2',\n",
       "  1),\n",
       " ('B-Lymphoblastic Leukemia/Lymphoma', 1),\n",
       " ('Endometrial Cancer', 1),\n",
       " ('Inflammatory Myofibroblastic Tumor', 1),\n",
       " ('Ganglioglioma', 1),\n",
       " ('Melanoma', 1),\n",
       " ('Hepatobiliary Cancer', 1)]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from collections import Counter\n",
    "Counter(cancer_types).most_common()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "1715c003",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(\"['Oncogenic Mutations']\", 13),\n",
       " (\"['Amplification']\", 4),\n",
       " (\"['Fusions']\", 3),\n",
       " (\"['D402N,L474P,S478N,E318K']\", 2),\n",
       " (\"['Exon 19 in-frame deletions,L858R']\", 2),\n",
       " (\"['L861Q']\", 2),\n",
       " (\"['G1202R']\", 2),\n",
       " (\"['G2032R']\", 1),\n",
       " (\"['L1196M']\", 1),\n",
       " (\"['T790M']\", 1),\n",
       " (\"['Oncogenic Mutations (excluding V600)']\", 1),\n",
       " (\"['T315I']\", 1),\n",
       " (\"['BCR-ABL1 Fusion']\", 1),\n",
       " (\"['G12C']\", 1),\n",
       " (\"['V299L,F317L,F317I,F317C,T315A,F317V']\", 1),\n",
       " (\"['V600E']\", 1),\n",
       " (\"['D816']\", 1),\n",
       " (\"['V600E,V600K']\", 1),\n",
       " (\"['Y823D']\", 1),\n",
       " (\"['G595R']\", 1)]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Counter(biomarkers).most_common()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dfd8723c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
